Meghmani Organics Limited (NSE:MOL)
India · Delayed Price · Currency is INR 50.12
-1.51 (-2.92%)
May 27, 2026, 3:30 PM IST
Meghmani Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 21,740 | 20,797 | 15,663 | 25,526 | 24,985 | |
Revenue Growth (YoY) | 4.53% | 32.78% | -38.64% | 2.17% | 52.66% |
Cost of Revenue | 13,261 | 12,878 | 10,450 | 15,358 | 14,754 |
Gross Profit | 8,478 | 7,920 | 5,213 | 10,168 | 10,231 |
Selling, General & Admin | 1,355 | 1,157 | 1,169 | 1,308 | 1,208 |
Other Operating Expenses | 5,359 | 5,320 | 4,236 | 5,445 | 5,230 |
Operating Expenses | 7,903 | 7,558 | 6,328 | 7,523 | 7,065 |
Operating Income | 574.92 | 361.2 | -1,116 | 2,645 | 3,166 |
Interest Expense | -918.6 | -648.26 | -456.31 | -417.16 | -69.27 |
Interest & Investment Income | - | 42.42 | 118.31 | 175.74 | 177.81 |
Earnings From Equity Investments | -0.06 | - | - | - | - |
Currency Exchange Gain (Loss) | - | 355.63 | 207.03 | 761.08 | 449.78 |
Other Non Operating Income (Expenses) | 964.16 | -37.68 | 12.78 | -235.17 | -21.6 |
EBT Excluding Unusual Items | 620.42 | 73.31 | -1,234 | 2,929 | 3,703 |
Gain (Loss) on Sale of Investments | - | 1.56 | 21.85 | 9.45 | 124.41 |
Gain (Loss) on Sale of Assets | - | -15.09 | -9.42 | -5.25 | -7.42 |
Other Unusual Items | - | 34.93 | 9.55 | 197.3 | 207.18 |
Pretax Income | 620.42 | 94.7 | -1,212 | 3,131 | 4,088 |
Income Tax Expense | 333.02 | 200.71 | -151.52 | 753.77 | 1,044 |
Earnings From Continuing Operations | 287.4 | -106.01 | -1,060 | 2,377 | 3,044 |
Net Income | 287.4 | -106.01 | -1,060 | 2,377 | 3,044 |
Net Income to Common | 287.4 | -106.01 | -1,060 | 2,377 | 3,044 |
Net Income Growth | - | - | - | -21.92% | 63.25% |
Shares Outstanding (Basic) | 254 | 254 | 254 | 254 | 254 |
Shares Outstanding (Diluted) | 254 | 254 | 254 | 254 | 254 |
Shares Change (YoY) | 0.01% | - | - | - | - |
EPS (Basic) | 1.13 | -0.42 | -4.17 | 9.35 | 11.97 |
EPS (Diluted) | 1.13 | -0.42 | -4.17 | 9.35 | 11.97 |
EPS Growth | - | - | - | -21.92% | 63.25% |
Free Cash Flow | 1,767 | -226.88 | -165.29 | -2,607 | -1,787 |
Free Cash Flow Per Share | 6.95 | -0.89 | -0.65 | -10.25 | -7.03 |
Dividend Per Share | - | - | - | 1.400 | 1.400 |
Gross Margin | 39.00% | 38.08% | 33.28% | 39.83% | 40.95% |
Operating Margin | 2.65% | 1.74% | -7.12% | 10.36% | 12.67% |
Profit Margin | 1.32% | -0.51% | -6.77% | 9.31% | 12.18% |
Free Cash Flow Margin | 8.13% | -1.09% | -1.05% | -10.21% | -7.15% |
EBITDA | 1,764 | 1,416 | -220.44 | 3,388 | 3,771 |
EBITDA Margin | 8.12% | 6.81% | -1.41% | 13.27% | 15.09% |
D&A For EBITDA | 1,190 | 1,055 | 895.13 | 742.94 | 604.78 |
EBIT | 574.92 | 361.2 | -1,116 | 2,645 | 3,166 |
EBIT Margin | 2.65% | 1.74% | -7.12% | 10.36% | 12.67% |
Effective Tax Rate | 53.68% | 211.94% | - | 24.08% | 25.53% |
Revenue as Reported | 22,704 | 21,236 | 16,040 | 26,487 | 25,947 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.